The precise mechanism of the reaction of butadiene with Cp* 2 Sm(H) (Cp* = η 5 -C 5 Me 5 ) has been investigated on the basis of DFT calculations. The initial coordination of butadiene to the Cp* 2 Sm(H) moiety was found to be η 2 -fashion, η 4 -coordination being sterically difficult. The experimentally known insertion product, Cp* 2 Sm(η 3 -CH 2 CHCHMe) ( 1a ), where the methyl group is in the syn position, is thermodynamically more stable than the anti -isomer ( 1c ) by 5.7 kcal/mol. The anti → syn transformation, i.e., isomerization of 1c to 1a, is possible via an intermediate with an η 1 -CH(Me)CH CH 2 ligand but requires a rather high energy barrier of 22 kcal/mol. Rotational motion of the allylic ligand in 1a takes place through a [Sm-η 1 -CH 2 CH CHMe] intermediate, i.e., through another η 3 → η 1 change of the allylic coordination or dissociation of the double bond. Complex 1a can be formed directly by the insertion of an η 2 -coordinated trans -butadiene to the Sm−H bond through an early transition state with very small activation energy. In contrast, 1c is derived from a complex with an η 2 -coordinated cis -butadiene via an η 1 -butenyl intermediate complex. The syn -configurated η 3 -butenyl complex 1a is thus the most preferred product in terms of both kinetics and thermodynamics.
No takes yet. Share an insight, caveat, or question.
Kaita et al. (2003) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: